NewsVoir http://newsvoir.com <![CDATA[Lasa Supergenerics Limited Announces Successful withdrawal of Application under Section 7 of I&B, 2016 Filed Against the Company by Financial Creditor]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=30215 <![CDATA[Lasa Secures Bulk Order of Rs. 500 Million]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=20164 <![CDATA[Lasa Supergenerics PAT at 12.35 Cr up by Robust 362 percent as Compared to Loss of 4.71 Cr in Q3FY22]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=20028 <![CDATA[Lasa Supergenerics Resumes Operations in All Units Situated in Mahad and Chiplun]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=17436 <![CDATA[LASA Launches New Product - Oxyclozanide]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=16713 <![CDATA[Lasa Supergenerics Announces Robust PAT at Rs. 22.80 Crs, up 521 Percent YoY, with Recommendation of Dividend]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=16641 <![CDATA[Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154% YoY Finance Cost Reduced by 95.40% YoY ]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=15619 <![CDATA[LASA Receives WHO Nod for its Khed Unit in Ratnagiri]]> http://newsvoir.com/index.php?option=com_content&view=release&rid=15453